David Vance
Clinical Cardiac Electrophysiology · Jonesboro, ARNPI 1205001799
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,066 of the $8,712 with a category attached, or 81.1%. Abbott accounts for 64.6% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $3,231 and has fallen 75.7% since, to $786 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in AR, where the typical reported total is $22,678.
Across 250 payments — averaging $34.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Biosense Webster, Inc.$887
- Medtronic$560
- Boston Scientific$478
- Johnson & Johnson$208
- Novartis$196
- plus $754 from 18 others
What the payments were for
- Travel & lodging$1,64619%
- Food & beverage$7,06681%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 123 | $5,630 |
| Biosense Webster, Inc. | 40 | $887 |
| Medtronic(2 entities) | 13 | $560 |
| Boston Scientific | 18 | $478 |
| Johnson & Johnson | 13 | $208 |
| Novartis | 12 | $196 |
| Atricure, Inc. | 2 | $156 |
| Daxor Corporation | 1 | $93 |
| Philips North America LLC | 2 | $90 |
| Abiomed | 3 | $80 |
| Pfizer | 6 | $73 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $57 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Avinger Inc. | 1 | $25 |
| AstraZeneca | 2 | $23 |
| Terumo Medical Corporation | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Edwards Lifesciences | 1 | $13 |
| Acutus Medical, Inc. | 1 | $13 |
| Amgen | 1 | $12 |
| Cardinal Health 200 LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$1,583
- CardioMEMS HF System$215
- ENSITE$160
- Assurity Pacemaker$155
- ACCENT$137
- QDOT MICRO Catheter$123
- Quadra Allure MP RF CRT Pacemkr$119
- Confirm Rx$103
- GENERAL - STENTS$101
How this compares
$8,712 in reported general payments places this provider in the 25th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
See all clinical cardiac electrophysiology providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 951 | $685,414 |
| XareltoRivaroxaban | 132 | $88,292 |
| EntrestoSacubitril/Valsartan | 20 | $16,199 |
| Dofetilide | 91 | $12,407 |
| SotalolSotalol Hcl | 527 | $7,465 |
| Flecainide Acetate | 230 | $7,260 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 19 | $4,189 |
| Amiodarone Hcl | 367 | $3,360 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 101 | $2,233 |
| Metoprolol Succinate | 149 | $1,567 |
| Metoprolol Tartrate | 312 | $1,180 |
| Carvedilol | 187 | $825 |
| Mexiletine Hcl | 13 | $740 |
| Digoxin | 58 | $691 |
| Propranolol Hcl | 13 | $600 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $73 | $685,414951 claims |
| Johnson & JohnsonXarelto | $208 | $88,292132 claims |
| NovartisEntresto | $196 | $16,19920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
Other clinical cardiac electrophysiology in Jonesboro
- Devi NairJonesboro$1.8M
- Oreoluwa OladiranJonesboro$80K
- Raphael NgengweJonesboro$47K
- Monica LoLittle Rock$190K
- Sudarone ThihalolipavanLittle Rock$77K
- Prabhat HebbarLittle Rock$75K
- Bilal SaqiNorth Little Rock$44K
- Gerald GreerLittle Rock$41K
- Risheek KaulLittle Rock$38K
- Yang YangFayetteville$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.